Association between expedited review designations and the US or global burden of disease for drugs approved by the US Food and Drug Administration, 2010-2019: a cross-sectional analysis.

BMJ Open · 2024 · PMC10936494 · PMID 38471684

Europe PMC DOI

hedged sentences

—

closest p

—

boldest claim

The sentences

a negative trendno p-value reported

There was a negative trend in the fraction of drugs with at least one expedited review designation across quartiles for either US or global DALYs ( figure 2B ).

also in 2,315 other papers

a positive trendno p-value reported

There was a positive trend in the fraction of drugs having at least one expedited designation across quartiles of either US or global YLL ( figure 2B ).

also in 6,397 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.